izpis_h1_title_alt

Gensko spremenjene mlečnokislinske bakterije kot dostavni sistemi za biološka zdravila
Berlec, Aleš (Author), Štrukelj, Borut (Author)

URLURL - Presentation file, Visit http://www.dlib.si/details/URN:NBN:SI:doc-I0QD6AHD New window

Abstract
Mlečnokislinske bakterije so že stoletja sestavni del človeške prehrane, zato je njihova varnost splošno priznana. Poleg tega so se v novejšem času visoko razvile tehnike, ki omogočajo rekombinantno izražanje proteinov tudi v mlečnokislinskih bakterijah. Zaradi teh razlogov imajo velik potencial kot poceni in učinkoviti dostavni sistemi za dostavo rekombinantnih proteinov na telesne sluznice, predvsem v prebavnem traktu. V razvoju in študijah na živalih so sistemi za dostavo antigenov (cepiv), dostavo proteinov s fiziološko funkcijo in dostavo DNA z namenom cepljenja. Dostava interlevkina IL-10 pri kronični vnetni črevesni bolezni se je izkazala za najbolj obetavno in je bila uspešno testirana v 1. fazi klinične študije na ljudeh. Pred splošno uporabo bo potrebno odgovoriti na vprašanja o varnosti vnosa genskega materiala, ker gre za gensko spremenjene organizme, ki ne uživajo podpore javnosti.

Language:Slovenian
Keywords:mlečnokislinske bakterije, rekombinantno izražanje, dostavni sistem, IL-10, gensko spremenjeni organizmi
Work type:Not categorized (r6)
Tipology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Year:2008
Publisher:Slovensko farmacevtsko društvo
Number of pages:str. 115-120
Numbering:Let. 59, št. 3
UDC:577.2
ISSN on article:0014-8229
COBISS.SI-ID:2364017 Link is opened in a new window
Views:808
Downloads:97
Metadata:XML RDF-CHPDL DC-XML DC-RDF
 
Average score:(0 votes)
Your score:Voting is allowed only to logged in users.
:
Share: Bookmark and Share

Record is a part of a journal

Title:Farmacevtski vestnik
Shortened title:Farm. vestn.
Publisher:Slovensko farmacevtsko društvo
ISSN:0014-8229
COBISS.SI-ID:3105794 New window

Secondary language

Language:English
Title:Genetically modified lactic acid bacteria as delivery systems for biopharmaceuticals
Abstract:
Lactic acid bacteria have been a part of human diet for centuries and their safety is therefore generally recognised. Apart from that, the techniques thatenable recombinant protein expression in lactic acid bacteria have recently developed. This is why lactic acid bacteria could serve as a cheap and efficient delivery system for recombinant protein delivery to body mucosa,especially in gastrointestinal tract. Systems for antigen (vaccine) delivery, delivery of proteins with physiological function and for DNA delivery are under development and in animal testing. The delivery of interleukin IL-10 in inflammatory bowel disease is the most promising and was successfully tested in phase I human clinical trial. Before the widespread use, questions regarding safety of genetic material introduction will have to be answered, since these are genetically modified organisms, which are not well accepted by the general public.


Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Comments

Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back